APPLICATION
ANDA207433
TYPE
ANDA
ORIGINAL APPROVAL
2016-05-05
LATEST ACTION
2019-04-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 75MG · TABLET · ORAL
DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 25MG · TABLET · ORAL
DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 100MG · TABLET · ORAL
DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 50MG · TABLET · ORAL
DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 10MG · TABLET · ORAL
DESIPRAMINE HYDROCHLORIDEDiscontinued
DESIPRAMINE HYDROCHLORIDE 150MG · TABLET · ORAL
Approval history
2019-04-16Labeling · Supplement 3 · standardAP
2016-05-05UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.